secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aspira Women's Health Inc. (AWHL)
CIK:        0000926617
Form:       8-K
Filed at:   2024-06-27T23:59:59+00:00
Accession:  0000950170-24-078612
Event type: leadership
Sentiment:  negative
Materiality: 0.75
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Aspira Women's Health CFO Torsten Hombeck terminated for cause; CEO interim CFO
-------------------------------------------------------------------------------

- Dr. Torsten Hombeck terminated as CFO on June 27, 2024 due to personal civil matter unrelated to Company.
- Termination deemed 'for cause' under employment agreement; no further payments beyond June 28, 2024 salary.
- CEO Nicole Sandford assumes CFO duties on interim basis; search for permanent replacement underway.
- Separate June 5, 2024 amendment had raised Hombeck's base salary to $375,000 and added Corporate Secretary title.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/926617/000095017024078612/0000950170-24-078612-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/926617/000095017024078612/awh-20240627.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-078612

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer